Demonstrating Medical Impact Through Outcomes

STUDY OVERVIEW
BENCHMARK CLASS
SPECIAL OFFER

Non-members: Click here to review a complimentary excerpt from “CNS Medical Affairs Impact Equation: Demonstrating Strategic Impact Through Outcomes and Data”

STUDY OVERVIEW

CNS Medical Affairs is entering a new era of evidence-backed strategic accountability. To sustain influence and investment, Medical teams must move beyond activity reporting to clearly link their work to real-world outcomes—ranging from improved patient pathways and clinician education to greater access and adoption.

This study examines how CNS teams use lagging indicators—including patient adoption, guideline concordance, and health outcomes—and real-world data to showcase strategic contributions. It evaluates which outcomes are most valued by stakeholders, how they are linked to prior Medical activities, and what data sources provide robust validation. This study also provides frameworks for outcome measurement, explores data granularity across multiple platforms, and highlights best practices to overcome challenges in linking CNS tactics to measurable results.

This resource equips senior CNS Medical leaders to quantify Medical’s strategic influence, refine outcome-driven frameworks, and elevate the value proposition of Medical Affairs in shaping patient care and organizational success.

KEY TOPICS

Measuring Lagging Indicators of CNS Medical Impact
Linking Strategic Outcomes to Medical Activities
Real-World Data Integration for Impact Validation
Data Granularity and Source Optimization
Challenges in Demonstrating Outcomes in CNS

KEY METRICS

Prioritization of strategic outcomes and linkability to Medical activities
Gap analysis between outcome importance and measurability
Trends in linking lagging indicators across CNS portfolios
Role of RWD and provider-level data in tracing Medical impact
Measuring influence on launch readiness, guidelines, and access decisions
Comparing perceived vs. measured Medical impact
Key challenges in linking medical tactics to strategic outcomes
Tailoring metrics to lifecycle maturity and product type
Updating outcome frameworks to align with evolving objectives
Balancing competing strategic priorities within CNS Medical Affairs
Identifying critical data sources and optimizing data granularity to strengthen impact measurement

SAMPLE KEY FINDINGS

Top Measurement Hurdle Hinges on Too Many Market Variables To Clearly Link Action to Outcome: 71% of surveyed Medical organizations cite this is a major challenge. Meanwhile, 50% indicate “we don’t know what outcomes to measure” and 43% cite limited resources/data and compliance hurdles as critical challenges.

Lagging Indicators Vary by Product Stage: 78% of organizations use different lagging indicators for launches versus mature therapies, showing a lifecycle-aware approach. This reinforces the importance of tailoring measurement strategies to product maturity to ensure relevance and strategic alignment.

METHODOLOGY

Best Practices, LLC engaged 16 Medical Affairs executives from 12 CNS-focused biopharma companies in this benchmarking research. In-depth interviews further provide insights on how CNS Medical Affairs teams are demonstrating strategic impact through outcomes and data.

Industries Profiled:
Pharmaceutical; Biopharmaceutical; Biotech; Health Care; Medical Device

Companies Profiled:
AbbVie; Alnylam Pharmaceuticals; Amgen; Azurity Pharmaceuticals; Boehringer Ingelheim; Eurofarma; Jazz Pharmaceuticals; Johnson & Johnson; Otsuka; Scholar Rock; Supernus; Takeda

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.

CNS Medical Affairs Impact Equation: Demonstrating Strategic Impact Through Outcomes and Data

ID: 5898

Features:

Pages/Slides: 33

Published: 2025

Delivery Format: Online PDF Document

RELATED RESEARCH

1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
61F1DAB113B33D9D900258D2600489F69
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-cns-medical-affairs-impact-equation-demonstrating-strategic-outcomes-data
18
19
20216.73.216.60
21
22
23www.emed24.net
24/bestp/domrep.nsf
25DB